"10.1371_journal.pbio.1001208","plos biology","2011-11-29T00:00:00Z","Kimberly Pelak; Anna C Need; Jacques Fellay; Kevin V Shianna; Sheng Feng; Thomas J Urban; Dongliang Ge; Andrea De Luca; Javier Martinez-Picado; Steven M Wolinsky; Jeremy J Martinson; Beth D Jamieson; Jay H Bream; Maureen P Martin; Persephone Borrow; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; Mary Carrington; David B Goldstein; Galit Alter; on behalf of NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)","Center for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, United States of America; Global Health Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, United States of America; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy; Division of Infectious Diseases, Siena University Hospital, Siena, Italy; irsiCaixa Foundation and Hospital Germans Trias i Pujol, Badalona, Spain; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Department of Medicine, David Geffen School of Medicine, University of California–Los Angeles, Los Angeles, California, United States of America; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, United States of America; Nuffield Department of Clinical Medicine, University of Oxford and Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom; Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America; Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America; Institute of Microbiology, University Hospital Center; and University of Lausanne, Lausanne, Switzerland; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America","The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: KP ACN TJU DBG GA. Performed the experiments: KP ACN KVS MPM AT GA. Analyzed the data: KP ACN JF SF DG GA. Contributed reagents/materials/analysis tools: ADL JMP SMW JJM BDJ JHB GA. Wrote the paper: KP JF DBG GA. Provided intellectual input: PB NLL AJM BFH AT MC.","The authors have declared that no competing interests exist.","2011","11","Kimberly Pelak","KP",23,FALSE,5,6,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
